Farrokhyar, Forough
Skorzewski, Philip
Phillips, Mark R. http://orcid.org/0000-0003-0923-261X
Garg, Sunir J.
Sarraf, David
Thabane, Lehana http://orcid.org/0000-0003-0355-9734
Bhandari, Mohit http://orcid.org/0000-0001-9608-4808
Chaudhary, Varun http://orcid.org/0000-0002-9988-4146
Wykoff, Charles C.
Sivaprasad, Sobha
Kaiser, Peter
Bakri, Sophie J.
Singh, Rishi P.
Holz, Frank G.
Wong, Tien Y.
Guymer, Robyn H.
,
Article History
Received: 12 January 2022
Revised: 17 January 2022
Accepted: 18 January 2022
First Online: 31 January 2022
Competing interests
: FF: Nothing to disclose. PS: Nothing to disclose. MRP: Nothing to disclose. SJG: Consultant: Allergan, Apellis, Bausch and Lomb, Boehringer Ingelheim, Johnson and Johnson, Kanaph; Research funds: American Academy of Ophthalmology, Apellis, Boehringer Ingelheim, NGM Bio, Regeneron—unrelated to this study. DS: Consultant: Amgen, Bayer, Genentech, Novartis, Optovue; Research funds: Amgen, Genentech, Heidelberg, Optovue, Regeneron, Topcon—unrelated to this study. LT: Nothing to disclose. MB: Research funds: Pendopharm, Bioventus, Acumed—unrelated to this study. VC: Advisory board member: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis—unrelated to this study.
Free to read: This content has been made available to all.